To determine if inflammatory cytokine signaling contributes to ADAR1 activation in MM, as reported in other contexts12,33, we treated the 1q-amplified human myeloma cell line H929 with increasing concentrations of IL-6 (0–10 ng/ml) in vitro. Here, IL6 is linked to Miyoshi myopathy.